Rein Therapeutics, Inc. (RNTX) — 10-K/A Filings
All 10-K/A filings from Rein Therapeutics, Inc.. Browse 3 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (3)
- 10-K/A Filing — Apr 27, 2026
-
Rein Therapeutics Files 2024 Annual Report Amendment
— Apr 30, 2025 Risk: low
Rein Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Aileron The -
Aileron Therapeutics Files 10-K/A Amendment
— Apr 29, 2024 Risk: low
Aileron Therapeutics, Inc. (RNTX) filed a Amended Annual Report (10-K/A) with the SEC on April 29, 2024. Aileron Therapeutics, Inc. filed an amendment (10-K/A)
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX